Does Trintellix (vortioxetine) interact with Buspar (buspirone)?

Drug Interaction Between Trintellix (Vortioxetine) and Buspar (Buspirone)

Yes, Trintellix and Buspar do interact—specifically, they both increase serotonergic activity and can cause serotonin syndrome when combined, requiring careful monitoring and potentially lower doses. 1

Mechanism of Interaction

Trintellix (vortioxetine) is explicitly listed in the FDA label as having a clinically important interaction with buspirone due to increased risk of serotonin syndrome. 1 The FDA drug label for Trintellix specifically names buspirone among "Other Serotonergic Drugs" that increase serotonin syndrome risk when used concomitantly. 1

• Vortioxetine acts as a serotonin reuptake inhibitor and modulates multiple serotonin receptors (5-HT1A agonist, 5-HT3/5-HT7/5-HT1D antagonist, 5-HT1B partial agonist). 2, 3
• Buspirone is a 5-HT1A partial agonist that affects serotonergic neurotransmission. 4
• The combination creates additive serotonergic effects through overlapping mechanisms at 5-HT1A receptors and overall serotonin enhancement. 1

Clinical Management

Monitor for serotonin syndrome symptoms when using this combination, and consider discontinuing one or both agents if serotonin syndrome develops. 1

Signs of Serotonin Syndrome to Monitor:

• Mental status changes (confusion, agitation, restlessness) 5
• Neuromuscular abnormalities (tremor, myoclonus, hyperreflexia, muscle rigidity, clonus) 5
• Autonomic hyperactivity (hypertension, tachycardia, diaphoresis, hyperthermia, diarrhea) 5
• Severe cases: fever, seizures, arrhythmias, unconsciousness 5

Dosing Considerations:

• Start buspirone at low doses (5 mg twice daily) when combined with vortioxetine. 6
• Titrate slowly, monitoring for symptoms at each dose increase. 6
• Maximum buspirone dose should generally not exceed 60 mg/day when combined with other serotonergic agents. 6
• Vortioxetine dosing (5-20 mg daily) does not require adjustment based solely on buspirone co-administration, but clinical response and tolerability should guide dosing. 3

Important Clinical Considerations

This combination can be used safely with appropriate monitoring, but requires vigilance particularly in the first 24-48 hours after initiation or dose changes. 5

• Case reports document serotonin syndrome developing when buspirone is added to SSRIs like fluoxetine, demonstrating real-world risk with serotonergic combinations. 7
• Symptoms can develop rapidly (within hours) or gradually over several weeks. 5, 7
• The risk is higher when combining two or more serotonergic drugs, even when neither is an MAOI. 5

Additional Monitoring:

• Assess patients within 1-2 weeks of initiating the combination for excessive sedation or serotonergic symptoms. 8
• Buspirone may take 2-4 weeks to become fully effective, so early discontinuation due to lack of efficacy should be avoided. 6
• Both medications have minimal effects on cytochrome P450 metabolism that would affect each other's levels—the interaction is pharmacodynamic, not pharmacokinetic. 3, 9

Contraindications

Do not combine either medication with MAOIs or within 14-21 days of MAOI discontinuation due to severe serotonin syndrome risk. 1

• Trintellix is contraindicated within 14 days of stopping an MAOI or within 21 days after stopping Trintellix before starting an MAOI. 1
• Other high-risk combinations to avoid with this regimen include linezolid, methylene blue, tramadol, and other potent serotonergic agents. 5, 1